399
Participants
Start Date
March 31, 2011
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
Armodafinil
Armodafinil tablets, taken orally, once daily in the morning
Placebo
Matching placebo tablets, taken orally, once daily in the morning
Teva Investigational Site 225, Birmingham
Teva Investigational Site 295, Sherman Oaks
Teva Investigational Site 122, Temecula
Teva Investigational Site 606, Jacksonville Beach
Teva Investigational Site 127, Lauderhill
Teva Investigational Site 608, Tampa
Teva Investigational Site 116, Atlanta
Teva Investigational Site 205, Atlanta
Teva Investigational Site 195, Park Ridge
Teva Investigational Site 611, Indianapolis
Teva Investigational Site 600, Lafayette
Teva Investigational Site 603, Watertown
Teva Investigational Site 207, Brooklyn
Teva Investigational Site 202, New York
Teva Investigational Site 110, Staten Island
Teva Investigational Site 411, Staten Island
Teva Investigational Site 614, Wilmington
Teva Investigational Site 610, Cincinnati
Teva Investigational Site 615, Toledo
Teva Investigational Site 401, Oklahoma City
Teva Investigational Site 609, Oklahoma City
Teva Investigational Site 616, Oklahoma City
Teva Investigational Site 406, Allentown
Teva Investigational Site 403, DeSoto
Teva Investigational Site 612, Friendswood
Teva Investigational Site 408, Salt Lake City
Teva Investigational Site 613, Kirkland
Teva Investigational Site 605, Spokane
Teva Investigational Site 134, Buenos Aires
Teva Investigational Site 136, Buenos Aires
Teva Investigational Site 881, Buenos Aires
Teva Investigational Site 884, Buenos Aires
Teva Investigational Site 888, Buenos Aires
Teva Investigational Site 236, Córdoba
Teva Investigational Site 135, Córdoba Capital
Teva Investigational Site 371, La Plata
Teva Investigational Site 886, La Plata
Teva Investigational Site 138, La Plata, Buenos Aires
Teva Investigational Site 882, Mendoza
Teva Investigational Site 883, Mendoza
Teva Investigational Site 885, Mendoza
Teva Investigational Site 887, Mendoza
Teva Investigational Site 238, Rosario
Teva Investigational Site 623, Belo Horizonte
Teva Investigational Site 626, Curitiba-Parana
Teva Investigational Site 621, Distrito de Rubiao Junior
Teva Investigational Site 627, Itapira -Sao Paulo
Teva Investigational Site 624, Rio de Janeiro
Teva Investigational Site 622, Salvador
Teva Investigational Site 628, São Paulo
Teva Investigational Site 248, Burgas
Teva Investigational Site 146, Kardzhali
Teva Investigational Site 148, Kazanlak
Teva Investigational Site 853, Pazardzhik
Teva Investigational Site 852, Pleven
Teva Investigational Site 145, Plovdiv
Teva Investigational Site 370, Rousse
Teva Investigational Site 147, Sofia
Teva Investigational Site 149, Sofia
Teva Investigational Site 244, Sofia
Teva Investigational Site 247, Sofia
Teva Investigational Site 854, Sofia
Teva Investigational Site 855, Sofia
Teva Investigational Site 245, Varna
Teva Investigational Site 851, Varna
Teva Investigational Site 856, Varna
Teva Investigational Site 635, Rijeka
Teva Investigational Site 631, Split
Teva Investigational Site 632, Zagreb
Teva Investigational Site 633, Zagreb
Teva Investigational Site 634, Zagreb
Teva Investigational Site 716, Helsinki
Teva Investigational Site 717, Helsinki
Teva Investigational Site 719, Kangasala
Teva Investigational Site 718, Turku
Teva Investigational Site 655, Achim
Teva Investigational Site 656, Berlin
Teva Investigational Site 653, Cologne
Teva Investigational Site 651, Dresden
Teva Investigational Site 654, Freiburg im Breisgau
Teva Investigational Site 652, Mittweida
Teva Investigational Site 661, Budapest
Teva Investigational Site 662, Budapest
Teva Investigational Site 664, Budapest
Teva Investigational Site 665, Győr
Teva Investigational Site 666, Nagykálló
Teva Investigational Site 688, Catania
Teva Investigational Site 689, Florence
Teva Investigational Site 686, Genova
Teva Investigational Site 691, Lido Di Camaiore(LU)
Teva Investigational Site 690, Naples
Teva Investigational Site 687, Pisa
Teva Investigational Site 693, Pisa
Teva Investigational Site 692, Roma
Teva Investigational Site 259, Bialystok
Teva Investigational Site 257, Gdansk
Teva Investigational Site 258, Gdynia
Teva Investigational Site 155, Krakow
Teva Investigational Site 255, Skorzewo
Teva Investigational Site 861, Szczecin
Teva Investigational Site 157, Tuszyn
Teva Investigational Site 177, Belgrade
Teva Investigational Site 831, Belgrade
Teva Investigational Site 832, Belgrade
Teva Investigational Site 835, Belgrade
Teva Investigational Site 176, Kragujevac
Teva Investigational Site 837, Niš
Teva Investigational Site 834, Novi Kneževac
Teva Investigational Site 700, Bojnice
Teva Investigational Site 699, Bratislava
Teva Investigational Site 697, Rimavská Sobota
Teva Investigational Site 696, Rožňava
Teva Investigational Site 698, Trenčín
Teva Investigational Site 707, Cape Town
Teva Investigational Site 709, Cape Town
Teva Investigational Site 712, Cape Town
Teva Investigational Site 708, Centurion
Teva Investigational Site 710, Johannesburg
Teva Investigational Site 711, Paarl
Teva Investigational Site 706, Pretoria
Teva Investigational Site 181, Dnipropetrovsk
Teva Investigational Site 872, Donetsk
Teva Investigational Site 282, Kharkiv
Teva Investigational Site 281, Kiev
Teva Investigational Site 180, Luhansk
Teva Investigational Site 873, Lviv
Teva Investigational Site 875, Odesa
Teva Investigational Site 183, Poltava
Teva Investigational Site 871, S. Oleksandrivka
Teva Investigational Site 182, Vinnytsia
Lead Sponsor
Cephalon
INDUSTRY